tradingkey.logo
tradingkey.logo
Search

FDA Approves Cabozantinib For Adults And Pediatric Patients 12 Years Of Age And Older With pNET And epNET

ReutersMar 26, 2025 12:37 PM
facebooktwitterlinkedin

- Exelixis Inc EXEL.O:

  • FDA APPROVES CABOZANTINIB FOR ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER WITH PNET AND EPNET

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI